TIM3 in COVID-19: A potential hallmark?
Author Information
Author(s): Zamani Mohammad Reza, Šácha Pavel
Primary Institution: Charles University, Prague, Czech Republic
Hypothesis
The review explores the role of TIM3 as an immune checkpoint in COVID-19 patients and its potential as a biomarker.
Conclusion
TIM3 expression is associated with the severity of COVID-19 and may serve as a potential biomarker for disease progression.
Supporting Evidence
- TIM3 is frequently upregulated in severe COVID-19 cases.
- Elevated TIM3 levels correlate with worse clinical outcomes in COVID-19 patients.
- TIM3 may serve as a biomarker for immune dysfunction in COVID-19.
Takeaway
TIM3 is a protein that can help doctors understand how the immune system is working in COVID-19 patients, especially those who are very sick.
Methodology
This is a review article summarizing existing studies on TIM3 in COVID-19 patients.
Potential Biases
Potential biases due to the variability in methodologies and clinical focus across studies.
Limitations
The studies reviewed are mostly retrospective and involve small sample sizes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website